20 Years of Funding Helping to improve the efficacy of cancer treatments, reduce their toxicity and improve the quality of life of patients. The Foundation funds innovative clinical or basic science research that will lead to novel therapeutic approaches that could replace, or be used in combination with existing effective therapies for patients with leukemia and lymphoma. Such therapeutic approaches could include alternative or complementary medicine.
Gabrielle’s Angel Foundation for Cancer Research funds the best and brightest early career scientists whose research focuses on finding less toxic treatments for patients with leukemia, lymphoma, and related blood cancers.
Since its inception in 1996, the Foundation has funded more than $35 million dollars in grants making it one of the largest non-governmental sources of grant support to blood cancer research in the nation. On average, ninety-two cents of every dollar raised directly funds research.
For more than two decades, the Foundation has honored Gabrielle’s legacy by funding the boldest, most cutting-edge ideas in cancer research.
Write a review